Monsanto Co. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co.

MTC 2.090

-3.2%

Nov 20 3:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jopawa who wrote (674)	12/1/1998 6:32:00 PM
From: Dan Spillane	Read Replies (1) of 2539

Good news on labeling! Here it is, they will allow the label to say Celebrex is safer... Silver Spring, Maryland, Dec. 1 (Bloomberg) -- Monsanto Co. won the backing of a U.S. Food and Drug Administration advisory panel for the first of a new class of painkillers with expected annual sales of as much as $5 billion. The FDA panel recommended the drug, known as Celebrex, be approved for patients with osteoarthritis or rheumatoid arthritis. It said the standard warning label for painkillers could be modified to indicate Celebrex has few side effects, which could help sales of the drug for other types of pain.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next